GoPeptideGuide.com

This site is intended for research purposes only. Peptides are not recommended for human consumption.

Menu
Menu

GHRP-6 (5mg)

Table of Contents

GHRP-6 (5mg)

Quickstart Highlights

GHRP-6 dosage protocols leverage this potent hexapeptide growth hormone secretagogue to stimulate natural GH release via the ghrelin receptor pathway[1]. By amplifying pulsatile GH secretion and raising IGF-1 levels, GHRP-6 supports enhanced muscle development, improved recovery, accelerated fat metabolism, and appetite stimulation[1][2]. Unlike exogenous GH, GHRP-6 preserves normal feedback loops without suppressing somatostatin[1]. This educational protocol outlines a three-times-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

  • Reconstitute: Add 2.5 mL bacteriostatic water → 2.0 mg/mL concentration.
  • Typical dose range: 100–300 mcg per injection, three times daily.
  • Easy measuring: At 2.0 mg/mL, 1 unit = 0.01 mL = 20 mcg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and dosing protocol

Standard Protocol (2.5 mL = 2.0 mg/mL)

PHASE DOSE PER INJECTION (mcg) UNITS (per injection) (mL)
Weeks 1–8 (Standard) 100 mcg 5 units (0.05 mL)
Weeks 1–8 (Moderate) 150 mcg 7.5 units (0.075 mL)
Weeks 1–8 (Advanced) 200–300 mcg 10–15 units (0.10–0.15 mL)

Frequency: Inject three times daily subcutaneously (Morning, Midday, Bedtime) to mimic natural pulsatile GH release[1]. Space injections at least 3–4 hours apart. Administer on an empty stomach (30+ minutes before eating) when possible, as elevated blood glucose may blunt GH response[3]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  • Draw 2.5 mL bacteriostatic water with a sterile syringe.
  • Inject slowly down the vial wall; avoid foaming.
  • Gently swirl/roll until dissolved (do not shake).
  • Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Protocol Overview

Concise summary of the three-times-daily regimen.

  • Goal: Stimulate natural pulsatile GH release to elevate IGF-1, supporting muscle growth, recovery, and metabolic function[1].
  • Schedule: Three subcutaneous injections daily for 8–12 weeks.
  • Dose Range: 100–300 mcg per injection (300–900 mcg total daily).
  • Reconstitution: 2.5 mL per 5 mg vial (2.0 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated up to 28 days; avoid repeated freeze–thaw.

Dosing Protocol

Suggested three-times-daily approach.

  • Standard: 100 mcg TID (300 mcg/day) — well-documented to significantly raise GH/IGF-1[1].
  • Moderate: 150 mcg TID (450 mcg/day) for enhanced response.
  • Advanced: 200–300 mcg TID (600–900 mcg/day) — upper practical limit.
  • Timing: Morning, Midday, Bedtime; 3–4 hours apart; ideally on empty stomach.
  • Cycle Length: 8–12 weeks; consider 1–2 week break after 3 months.

Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at −20 °C (−4 °F) for long-term; 2–8 °C (35.6–46.4 °F) acceptable for weeks[8].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 28 days with bacteriostatic water[9].
  • Allow vials to reach room temperature before opening to reduce condensation uptake.

Suppilies Needed

Plan based on an 8–12 week protocol with three-times-daily dosing at 100 mcg per injection (300 mcg/day total).

  • Peptide Vials (GHRP-6, 5 mg each):
    • 8 weeks (16.8 mg total) ≈ 4 vials
    • 12 weeks (25.2 mg total) ≈ 6 vials
  • Insulin Syringes (U-100, 30- or 50-unit preferred for precision):
    • Per week: 21 syringes (3/day)
    • 8 weeks: 168 syringes
    • 12 weeks: 252 syringes
  • Bacteriostatic Water (10 mL bottles): Use 2.5 mL per vial for reconstitution.
    • 8 weeks (4 vials): 10 mL → 1 × 10 mL bottle
    • 12 weeks (6 vials): 15 mL → 2 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each injection.
    • Per week: 42 swabs (2 × 3/day)
    • 8 weeks: 336 swabs → recommend 4 × 100-count boxes
    • 12 weeks: 504 swabs → recommend 6 × 100-count boxes
GHRP-6 (5mg)
View Supplier

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each injection; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
  • Inject slowly; wait a few seconds before withdrawing the needle.
  • GHRP-6 typically induces strong appetite within 20–30 minutes post-injection[5].
  • Document daily dose and site rotation to maintain consistency.

How This Works

GHRP-6 binds to the ghrelin receptor (GHS-R1a) on pituitary somatotrope cells, triggering robust pulsatile GH secretion through G-protein and phospholipase C activation[1]. Unlike exogenous GH, GHRP-6 preserves normal hypothalamic–pituitary feedback without suppressing somatostatin, allowing natural GH tapering[1]. Studies demonstrate that GHRP-6 can restore GH responsiveness even in obese subjects with blunted secretion, producing GH surges roughly twice as large as GHRH alone[3]. When combined with GHRH analogs, the synergistic effect yields massive GH discharge far exceeding either peptide individually[3]. The peptide has a short half-life of approximately 20 minutes, necessitating multiple daily administrations[1].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

  • Elevated GH/IGF-1: Consistent increases in circulating GH and IGF-1, supporting anabolic processes and body composition improvements[1][2].
  • Muscle and recovery: May enhance lean muscle mass, strength, and tissue repair through IGF-1 elevation[1].
  • Appetite stimulation: Pronounced ghrelin-mimetic hunger effect within 20–30 minutes post-injection; useful for cachexia or weight gain goals[5].
  • Sleep modulation: Studies show increased stage 2 sleep duration without major REM disruption[4].
  • Generally well tolerated: No serious adverse effects reported at moderate doses in human studies[1]. Mild injection-site reactions possible.
  • Transient hormonal effects: Brief elevation of ACTH and cortisol post-injection; usually clinically insignificant[4].

Lifestyle Factors

Complementary strategies for best outcomes.

  • Pair with a balanced, protein-forward diet tailored to energy needs.
  • Combine resistance training and aerobic activity to reinforce anabolic and metabolic adaptations.
  • Prioritize sleep quality—GH is naturally highest during deep sleep.
  • Administer on an empty stomach when possible to optimize GH response.
  • Be mindful of the appetite-stimulating effect if fat loss is a primary goal.

Injection Technique

General subcutaneous guidance from clinical best-practice resources[6][7].

  • Clean the vial stopper and skin with alcohol; allow to dry.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[6].
  • Do not aspirate for subcutaneous injections; inject slowly and steadily[6].
  • Wait 5 seconds after injection before withdrawing the needle[7].
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[7].

Recommended Source

We recommend Go Alpha Labs for high-purity GHRP-6 (5 mg).

Why Go Alpha Labs?​

  • Verifies ≥99% purity through independent lab testing
  • Trusted by researchers seeking reliable results
  • Follows rigorous manufacturing standards for consistent quality
Shop at Go Alpha Labs

Important Note:

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

 

References:

 

Source Link
PMC — The Safety and Efficacy of Growth Hormone Secretagogues
— Comprehensive review of GHRP-6 mechanism, dosing, GH/IGF-1 effects, and safety profile		 View Source
PubMed — Pharmacokinetic study of GHRP-6 in healthy volunteers
— Human pharmacokinetic data, dose-response, and tolerability at high doses		 View Source
PubMed — Massive GH discharge after combined GHRH and GHRP-6
— Evidence for synergistic GH release and somatotroph secretory capacity in obesity		 View Source
PubMed — GHRP-6 stimulates sleep, GH, ACTH and cortisol in normal man
— Human study on sleep architecture, stage 2 sleep, and transient hormonal effects		 View Source
PubMed — GHRP-6 mimics ghrelin-induced stimulation of food intake
— Preclinical evidence for potent appetite-stimulating (orexigenic) action		 View Source
CDC — Vaccine Administration: Subcutaneous Injection
— Technique guidance for subcutaneous route (angle, site, no aspiration)		 View Source
MedlinePlus — Giving an Insulin Injection
— Patient instructions for subcutaneous technique, site rotation, and needle handling		 View Source
NIBSC — Peptide Storage Guidelines
— Lyophilized peptide storage temperature recommendations and stability		 View Source
CDC — Safe Injection Practices for Multi-Dose Vials
— 28-day use guidance for bacteriostatic water and multi-dose vials		 View Source
Bachem — Care and Handling of Peptides
— Technical guidance on peptide reconstitution, storage, and stability		 View Source
PMC — Subcutaneous Drug Injection Review
— Pharmacologic considerations of the subcutaneous administration route		 View Source
Scroll to Top